INTEGRATED APPROACH TO SPLENOMEGALY

Non-Hodgkinâs lymphoma Lymphomas Dr. Sabir M. Amin Definition collection of lymphoid malignancies in which malignant lymphocytes accumulate in lymph nodes and lymphoid tissues,…

Cirrhosis of the liver Definition • Cirrhosis is a common chronic, progressive and diffusive liver disease, caused by one or several agents act repeatedly and persistently.…

PORTAL HYPERTENSION UNDER GUIDENCE OF DR. DESHMUKH SIR DR. JAMBHULKAR SIR DR. POTE SIR BY ASHOK SHINDE ANATOMY PHYSIOLOGY AND PATHOPHYSIOLOGY OF PORTAL HYPERTENSION The liver…

Chronic Myelogenius Leukemia • It’s clonal myeloproliferative disease arising from emmatural cells of a myelopoiesis which morphological substrate are mainly maturing…

1. Case discussion and topic review Moderator Dr. Naveen PandeyPresenter-Dr. Pradip katwal 2. • 35 years/ Female• Siraha• Housewife• Vegetarian– Presenting complains-•…

1. CHRONIC MYELOID LEUKEMIA Dr.A.MEENAKSHI PROF.S.TITO’S UNIT. M4 2. Definition Chronic myelogenous leukemia is a pluripotent stem cell disease characterized byanaemia,extreme…

Enzyme Replacement Therapy for Gaucher's DiseaseThis policy and any information contained herein is the property of Blue Cross Blue Shield of Michigan and its subsidiaries,

Drug Evaluation part of Velaglucerase alfa in the treatment of Gaucher disease type 1: an update K Nicole Weaver1, Gregory A Grabowski1 & Thomas A Burrow*,1 1Cincinnati

ADULT HAEMATOLOGY GP 14. Macrocytosis 15. Pancytopenia 16. Hyperferritinaemia Pathway Guide Lymphadenopathy | Clinical Lead: Dr Rachel Brown| V.3 | Created: 16/04/2020 Lymphadenopathy